Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

As enterprises increasingly prioritize the integration of AI into their operations, Avenue Code, a subsidiary of AI/R, has ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

But, even if that happens for one or two candidates, Vertex is still well-positioned to progressively expand its number of commercialized drugs and treatment areas. This, along with the ongoing ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Kuku FM’s ongoing fundraise has been positioned around rising demand for code-based mini dramas, reflecting investor interest ...

IT Concepts, Inc. doing business as Kentro (Kentro hereafter) was awarded a Department of Defense (DoD) National Geospatial-Intelligence Agency (NGA) VERTEX contract providing NGA with program and ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...

OpenAI has finalized a deal to sell employees’ shares to investors that values the artificial intelligence company at $500 ...